VEGFA and neoplasm: Among the seven selected peptides, F56 (WHSDMEWWYLLG) blocked VEGF binding to the Flt-1 receptor in vitro and inhibited blood vessel formation, tumor growth, and breast cancer metastasis in vivo [137].